Connective tissue growth factor: Context-dependent functions and mechanisms of regulation

BioFactors

Volumn 35, Issue 2, 2009, Pages 200-208

  Cicha, Iwona ^a   Goppelt Struebe, Margarete ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Angiogenesis; Connective tissue growth factor; Epigenetic

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; ANGIOGENESIS INHIBITOR;

ANGIOGENESIS; CELL TYPE; DNA MODIFICATION; FIBROSIS; GENE CONTROL; GENE EXPRESSION; HUMAN; PRIORITY JOURNAL; REVIEW; UPREGULATION; WOUND HEALING; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANGIOGENESIS INHIBITORS; ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION;

EID: 67349168833     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.30     Document Type: Review

References (112)

1. Chen, C. C., and Lau, L. F. Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem. Cell Biol. 10.1016/j.biocel.2008. 00260x.
2. de Winter, P., Leoni, P., and Abraham, D. (2008)Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors 26, 80-91.
3. Kubota, S., and Takigawa, M. (2007) CCN family proteins and angiogenesis: from embryo to adulthood. Angiogenesis 10, 1-11.
4. Desnoyers, L. (2004) Structural basis and therapeutic implication of the interaction of CCN proteins with glycoconjugates. Curr. Pharm. Des. 10, 3913-3928.
5. Grotendorst, G. R., and Duncan, M. R. (2005) Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J. 19, 729-738.
6. Bornstein, P., and Sage, E. H. (2002) Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell. Biol. 14, 608-616.
7. Rachfal, A. W., and Brigstock, D. R. (2005) Structural and functional properties of CCN proteins. Vitam. Horm. 70, 69-103.
8. Abraham, D. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?Rheumatology (Oxford) 2008;47 (Suppl 5), v8-v9.
9. Shi-Wen, X., Leask, A., and Abraham, D. (2008) Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 19, 133-144.
10. Leask, A., and Abraham, D. J. (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell. Sci. 119, 4803-4810.
11. Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda, D. E., Stephenson, R. C., Daluiski, A., and Lyons, K. M. (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130, 2779-2791.
12. Nishida, T., Kondo, S., Maeda, A., Kubota, S., Lyons, K. M., and Takigawa, M. (2009) CCN family 2/connective tissue growth factor (CCN2/ CTGF) regulates the expression of Vegf through Hif-1alpha expression in a chondrocytic cell line, HCS-2/8, under hypoxic condition. Bone 44, 24-31.
13. Shimo, T., Nakanishi, T., Nishida, T., Asano, M., Kanyama, M., Kuboki, T., Tamatani, T., Tezuka, K., Takemura, M., Matsumura, T., and Takigawa, M. (1999) Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J. Biochem. (Tokyo)126, 137-145.
14. Shimo, T., Kubota, S., Kondo, S., Nakanishi, T., Sasaki, A., Mese, H., Matsumura, T., and Takigawa, M. (2001) Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett. 174, 57-64.
15. Chintalapudi, M. R., Markiewicz, M., Kose, N., Dammai, V., Champion, K. J., Hoda, R. S., Trojanowska, M., and Hsu, T. (2008) Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells. Carcinogenesis 29, 696-703.
16. Brigstock, D. R. (2002) Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteinerich 61 (CYR61). Angiogenesis 5, 153-165.
17. Chang, C. C., Lin, M. T., Lin, B. R., Jeng, Y. M., Chen, S. T., Chu, C. Y., Chen, R. J., Chang, K. J., Yang, P. C., and Kuo, M. L. (2006) Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis. J. Natl. Cancer Inst. 98, 984-995.
18. Inoki, I., Shiomi, T., Hashimoto, G., Enomoto, H., Nakamura, H., Makino, K., Ikeda, E., Takata, S., Kobayashi, K., and Okada, Y. (2002) Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J. 16, 219-221.
19. Hashimoto, G., Inoki, I., Fujii, Y., Aoki, T., Ikeda, E., and Okada, Y. (2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J. Biol. Chem. 277, 36288-36295.
20. Ito, T. K., Ishii, G., Chiba, H., and Ochiai, A. (2007) The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene 26, 7194-7203.
21. Dean, R. A., Butler, G. S., Hamma-Kourbali, Y., Delbe, J., Brigstock, D. R., Courty, J., and Overall, C. M. (2007) Identification of Candidate Angiogenic Inhibitors Processed by MMP-2 in Cell Based Proteomic Screens: Disruption of VEGF/HARP (Pleiotrophin) and VEGF / CTGF Angiogenic Inhibitory Complexes by MMP-2 Proteolysis. Mol. Cell Biol. 27, 8454-8465.
22. Kuiper, E. J., Roestenberg, P., Ehlken, C., Lambert, V., Bloys van Treslong- de, G., Lyons, K. M., Agostini, H. J., Rakic, J. M., Klaassen, I., Van Noorden, C. J., Goldschmeding, R., and Schlingemann, R. O. (2007) Angiogenesis Is Not Impaired in Connective Tissue Growth Factor (CTGF) Knock Out Mice. J. Histochem. Cytochem. 55, 1139-1147.
23. Kuiper, E. J., Van Nieuwenhoven, F. A., de Smet, M. D., van Meurs, J. C., Tanck, M. W., Oliver, N., Klaassen, I., Van Noorden, C. J., Goldschmeding, R., and Schlingemann, R. O. (2008) The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS ONE 3, e2675.
24. Kuiper, E. J., van Zijderveld, R., Roestenberg, P., Lyons, K. M., Goldschmeding, R., Klaassen, I., Van Noorden, C. J., and Schlingemann, R. O. (2008) Connective tissue growth factor is necessary for retinal capillary basal lamina thickening in diabetic mice. J. Histochem. Cytochem. 56, 785-792.
25. Hahn, A., Heusinger-Ribeiro, J., Lanz, T., Zenkel, S., Goppelt-Struebe, M. (2000) Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by rho proteins and the actin cytoskeleton. J. Biol. Chem. 275, 37429-37435.
26. Kondo, S., Kubota, S., Eguchi, T., Hattori, T., Nakanishi, T., Sugahara, T., and Takigawa, M. (2000) Characterization of a mouse ctgf 3′-UTR segment that mediates repressive regulation of gene expression. Biochem. Biophys. Res. Commun. 278, 119-124.
27. Kondo, S., Kubota, S., Mukudai, Y., Moritani, N., Nishida, T., Matsushita, H., Matsumoto, S., Sugahara, T., and Takigawa, M. (2006) Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 30-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene 25, 1099-1110.
28. Burgess, J. K. (2005) Connective tissue growth factor: a role in airway remodelling in asthma?Clin. Exp. Pharmacol. Physiol. 32, 988-994.
29. Igarashi, A., Okochi, H., Bradham, D. M., and Grotendorst, G. R. (1993) Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol. Cell Biol. 4, 637-645.
30. Gupta, S., Clarkson, M. R., Duggan, J. (2000) Brady: Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int. 58, 1389-1399.
31. Grotendorst, G. R. (1997) Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 8, 171-179.
32. Fu, M., Zhang, J., Zhu, X., Myles, D. E., Willson, T. M., Liu, X., and Chen, Y. E. (2001) Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J. Biol. Chem. 276, 45888-45894.
33. Riser, B. L., Denichilo, M., Cortes, P., Baker, C., Grondin, J. M., Yee, J., and Narins, R. G. (2000) Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J. Am. Soc. Nephrol. 11, 25-38.
34. Abdel-Wahab, N., Weston, B. S., Roberts, T., and Mason, R. M. (2002) Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J. Am. Soc. Nephrol. 13, 2437-2445.
35. Gressner, O. A., Lahme, B., Siluschek, M., Rehbein, K., Herrmann, J., Weiskirchen, R., Gressner, A. M. Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor. J. Cell Mol. Med. 10.1111/j.1582-4934.2008. 00260.x.
36. Kroening, S., Solomovitch, S., Sachs, M., Wullich, B., and Goppelt- Struebe, M. Regulation of connective tissue growth factor (CTGF) by hepatocyte growth factor in human tubular epithelial cells. Nephrol. Dial. Transplant., 10.1093/ndt/gfn530.
37. Ruiz-Ortega, M., Rodriguez-Vita, J., Sanchez-Lopez, E., Carvajal, G., and Egido, J. (2007) TGF-beta signaling in vascular fibrosis. Cardiovasc. Res. 74, 196-206.
38. Milliat, F., Francois, A., Isoir, M., Deutsch, E., Tamarat, R., Tarlet, G., Atfi, A., Validire, P., Bourhis, J., Sabourin, J. C., and Benderitter, M. (2006) Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. Am. J. Pathol. 169, 1484-1495.
39. Arnott, J. A., Zhang, X., Sanjay, A., Owen, T. A., Smock, S. L., Rehman, S., DeLong, W. G., Safadi, F. F., and Popoff, S. N. (2008) Molecular requirements for induction of CTGF expression by TGF-beta1 in primary osteoblasts. Bone 42, 871-885.
40. Phanish, M. K., Wahab, N. A., Colville-Nash, P., Hendry, B. M., and Dockrell, M. E. (2006) The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximaltubule epithelial cells. Biochem. J. 393, 601-607.
41. Van Beek, J. P., Kennedy, L., Rockel, J. S., Bernier, S. M., and Leask, A. (2006) The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res. Ther. 8, R36.
42. Holmes, A., Abraham, D. J., Sa, S., Shiwen, X., Black, C. M., and Leask, A. (2001) CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J. Biol. Chem. 276, 10594-10601.
43. Leask, A., Holmes, A., Black, C. M., and Abraham, D. J. (2003) Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J. Biol. Chem. 278, 13008-13015.
44. Grotendorst, G. R., Okochi, H., and Hayashi, N. (1996) A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 7, 469-480.
45. Chen, Y., Blom, I. E., Sa, S., Goldschmeding, R., Abraham, D. J., and Leask, A. (2002) CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int. 62, 1149-1159.
46. Pickles, M., and Leask, A. (2007) Analysis of CCN2 promoter activity in PANC-1 cells: regulation by ras/MEK/ERK. J. Cell. Commun. Signal 1, 85-90.
47. Xu, S. W., Howat, S. L., Renzoni, E. A., Holmes, A., Pearson, J. D., Dashwood, M. R., Bou-Gharios, G., Denton, C. P., du Bois, R. M., Black, C. M., Leask, A., and Abraham, D. J. (2004) Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J. Biol. Chem. 279, 23098-23103.
48. Heusinger-Ribeiro, J., Eberlein, M., Wahab, N. A., Goppelt-Struebe, M. (2001) Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP. J. Am. Soc. Nephrol. 12, 1853-1861.
49. Phanish, M. K., Wahab, N. A., Hendry, B. M., and Dockrell, M. E. (2005) TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling. Nephron Exp. Nephrol. 100, e156-165.
50. Kasai, H., Allen, J. T., Mason, R. M., Kamimura, T., and Zhang, Z. (2005) TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6, 56.
51. Gressner, O. A., Lahme, B., Demirci, I., Gressner, A. M., and Weiskirchen, R. (2007) Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J. Hepatol. 47, 699-710.
52. Kwon, S., Munroe, X., Crawley, S. C., Lee, H. Y., Spong, S., Bradham, D., Gum, J. R., Jr., Sleisenger, M. H., and Kim, Y. S. (2007) Expression of connective tissue growth factor in pancreatic cancer cell lines. Int. J. Oncol. 31, 693-703.
53. Black, S. A., Jr., Palamakumbura, A. H., Stan, M., and Trackman, P. C. (2007) Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c- JUN N-terminal kinase. J. Biol. Chem. 282, 15416-15429.
54. Watts, K. L., and Spiteri, M. A. (2004) Connective Tissue Growth Factor expression and induction by Transforming Growth Factor {beta}, is abrogated by Simvastatin via a Rho signalling mechanism. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L1323-L1332.
55. Gomis, R. R., Alarcon, C., He, W., Wang, Q., Seoane, J., Lash, A., and Massague, J. (2006) A FoxO-Smad synexpression group in human keratinocytes. Proc. Natl. Acad. Sci. USA 103, 12747-12752.
56. Chiquet, M., Tunc-Civelek, V., Sarasa-Renedo, A. (2007) Gene regulation by mechanotransduction in fibroblasts. Appl. Physiol. Nutr. Metab. 32, 967-973.
57. Wells, R. G. (2008) The role of matrix stiffness in regulating cell behavior. Hepatology 47, 1394-1400.
58. Morgan, E. F., Gleason, R. E., Hayward, L. N., Leong, P. L., and Palomares, K. T. (2008) Mechanotransduction and fracture repair. J. Bone Joint Surg. Am. 90 (Suppl 1), 25-30.
59. Chaqour, B., and Goppelt-Struebe, M. (2006) Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins. FEBS J. 273, 3639-3649.
60. Hill, M. A., Davis, M. J., Meininger, G. A., Potocnik, S. J., and Murphy, T. V. (2006) Arteriolar myogenic signalling mechanisms: Implications for local vascular function. Clin. Hemorheol. Microcirc. 34, 67-79.
61. Chu, T. J., and Peters, D. G. (2008) Serial analysis of the vascular endothelial transcriptome under static and shear stress conditions. Physiol. Genomics 34, 185-192.
62. Lee, Y. S., Byun, J., Kim, J. A., Lee, J. S., Kim, K. L., Suh, Y. L., Kim, J. M., Jang, H. S., Lee, J. Y., Shin, I. S., Suh, W., Jeon, E. S., and Kim, D. K. (2005) Monocrotaline-induced pulmonary hypertension correlates with upregulation of connective tissue growth factor expression in the lung. Exp. Mol. Med. 37, 27-35.
63. Chaqour, B., Yang, R., and Sha, Q. (2006) Mechanical stretch modulates the promoter activity of the profibrotic factor CCN2 through increased actin polymerization and NF-kappa B activation. J. Biol. Chem. 281, 20608-20622.
64. Yoshisue, H., Suzuki, K., Kawabata, A., Ohya, T., Zhao, H., Sakurada, K., Taba, Y., Sasaguri, T., Sakai, N., Yamashita, S., Matsuzawa, Y., and Nojima, H. (2002) Large scale isolation of non-uniform shear stress-responsive genes from cultured human endothelial cells through the preparation of a subtracted cDNA library. Atherosclerosis 162, 323-334.
65. McCormick, S. M., Frye, S. R., Eskin, S. G., Teng, C. L., Lu, C. M., Russell, C. G., Chittur, K. K., and McIntire, L. V. (2003) Microarray analysis of shear stressed endothelial cells. Biorheology 40, 5-11.
66. McCormick, S. M., Eskin, S. G., McIntire, L. V., Teng, C. L., Lu, C. M., Russell, C. G., and Chittur, K. K. (2001) DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc. Natl. Acad. Sci. USA 98, 8955-8960.
67. Eskin, S. G., Turner, N. A., and McIntire, L. V. (2004) Endothelial cell cytochrome P450 1A1 and 1B1: up-regulation by shear stress. Endothelium 11, 1-10.
68. Garcia-Cardena, G., Comander, J., Anderson, K. R., Blackman, B. R., Gimbrone, M. A., Jr. (2001) Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc. Natl. Acad. Sci. USA 98, 4478-4485.
69. Cicha, I., Goppelt-Struebe, M., Muehlich, S., Yilmaz, A., Raaz, D., Daniel, W. G., and Garlichs, C. D. (2008) Pharmacological inhibition of RhoA signaling prevents connective tissue growth factor induction in endothelial cells exposed to non-uniform shear stress. Atherosclerosis 196, 136-145.
70. Cunningham, K. S., and Gotlieb, A. I. (2005) The role of shear stress in the pathogenesis of atherosclerosis. Lab. Invest. 85, 9-23.
71. Cicha, I., Yilmaz, A., Klein, M., Raithel, D., Brigstock, D. R., Daniel, W. G., Goppelt-Struebe, M., and Garlichs, C. D. (2005) Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler. Thromb. Vasc. Biol. 25, 1008-1013.
72. Sohn, M., Tan, Y., Wang, B., Klein, R. L., Trojanowska, M., and Jaffa, A. A. (2006) Mechanisms of low-density lipoprotein-induced expression of connective tissue growth factor in human aortic endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 290, H1624-1634.
73. Wang, X., LeMaire, S. A., Chen, L., Shen, Y. H., Gan, Y., Bartsch, H., Carter, S. A., Utama, B., Ou, H., Coselli, J. S., and Wang, X. L. (2006) Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation 114, I200-205.
74. Fan, W. H., Pech, M., and Karnovsky, M. J. (2000) Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. [In Process Citation].Eur. J. Cell Biol. 79, 915-923.
75. Muehlich, S., Schneider, N., Hinkmann, F., Garlichs, C. D., Goppelt- Struebe, M. (2004) Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine- 1-phosphate, and platelets. Atherosclerosis 175, 261-268.
76. Ruperez, M., Rodrigues-Diez, R., Blanco-Colio, L. M., Sanchez-Lopez, E., Rodriguez-Vita, J., Esteban, V., Carvajal, G., Plaza, J. J., Egido, J., Ruiz-Ortega, M. (2007) HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways. Hypertension 50, 377-383.
77. Graness, A., Giehl, K., Goppelt-Struebe, M. (2006) Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF). Cell Signal 18, 433-440.
78. Ott, C., Iwanciw, D., Graness, A., Giehl, K., Goppelt-Struebe, M. (2003) Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton. J. Biol. Chem. 278, 44305-44311. (Pubitemid 37377176)
79. Gettemans, J., Van Impe, K., Delanote, V., Hubert, T., Vandekerckhove, J., and De, C. V. (2005) Nuclear actin-binding proteins as modulators of gene transcription. Traffic 6, 847-857.
80. Treisman, R., Alberts, A. S., and Sahai, E. (1998) Regulation of SRF activity by Rho family GTPases. Cold Spring Harb. Symp. Quant. Biol. 63, 643-651.
81. Muehlich, S., Cicha, I., Garlichs, C. D., Krueger, B., Posern, G., Goppelt- Struebe, M. (2007) Actin-dependent regulation of connective tissue growth factor (CTGF). Am. J. Physiol. Cell Physiol. 292, 1732-1738.
82. Vartiainen, M. K. (2008) Nuclear actin dynamics--from form to function. FEBS Lett. 582, 2033-2040.
83. Olson, M. F. (2008) Applications for ROCK kinase inhibition. Curr. Opin. Cell. Biol. 20, 242-248.
84. Ying, H., Biroc, S. L., Li, W. W., Alicke, B., Xuan, J. A., Pagila, R., Ohashi, Y., Okada, T., Kamata, Y., and Dinter, H. (2006) The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Mol. Cancer Ther. 5, 2158-2164.
85. Oka, M., Fagan, K. A., Jones, P. L., and McMurtry, I. F. (2008) Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension. Br. J. Pharmacol. 155, 444-454.
86. Mita, S., Kobayashi, N., Yoshida, K., Nakano, S., and Matsuoka, H. (2005) Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats. J. Hypertens. 23, 87-96.
87. Vicari, R. M., Chaitman, B., Keefe, D., Smith, W. B., Chrysant, S. G., Tonkon, M. J., Bittar, N., Weiss, R. J., Morales-Ballejo, H., and Thadani, U. (2005) Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J. Am. Coll. Cardiol. 46, 1803-1811.
88. Samarin, J., Rehm, M., Krueger, B., Waschke, J., Goppelt-Struebe, M.: Upregulation of connective tissue growth factor (CTGF/CCN2) in endothelial cells by the microtubule destabilizing agent combretastatin A- 4. Mol. Cancer. Res. 1541-7786.MCR-08-0292v1.
89. Eberlein, M., Heusinger-Ribeiro, J., Goppelt-Struebe, M. (2001) Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). Br. J. Pharmacol. 133, 1172-1180. (Pubitemid 32762429)
90. Song, Y., Li, C., and Cai, L. (2004) Fluvastatin prevents nephropathy likely through suppression of connective tissue growth factor-mediated extracellular matrix accumulation. Exp. Mol. Pathol. 76, 66-75.
91. Gojo, A., Utsunomiya, K., Taniguchi, K., Yokota, T., Ishizawa, S., Kanazawa, Y., Kurata, H., and Tajima, N. (2007) The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 568, 242-247.
92. Steioff, K., Rutten, H., Busch, A. E., Plettenburg, O., Ivashchenko, Y., and Lohn, M. (2005) Long term Rho-kinase inhibition ameliorates endothelial dysfunction in LDL-Receptor deficient mice. Eur. J. Pharmacol. 512, 247-249.
93. Black, S. A., Jr., and Trackman, P. C. (2008) Transforming growth factor- beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN2/CTGF expression. J. Biol. Chem. 283, 10835-10847.
94. Giehl, K., Graness, A., and Goppelt-Struebe, M. (2008) The small GTPase Rac-1 is a regulator of mesangial cell morphology and thrombospondin- 1 expression. Am. J. Physiol. Renal. Physiol. 294, F407-413.
95. Chu, C. Y., Chang, C. C., Prakash, E., and Kuo, M. L. Connective tissue growth factor (CTGF) and cancer progression. J. Biomed. Sci. 15, 675-685.
96. Patra, S. K., Patra, A., Rizzi, F., Ghosh, T. C., and Bettuzzi, S. (2008) Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development. Cancer Metastasis Rev. 27, 315-334.
97. Kikuchi, R., Tsuda, H., Kanai, Y., Kasamatsu, T., Sengoku, K., Hirohashi, S., Inazawa, J., and Imoto, I. (2007) Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res. 67, 7095-7105.
98. Chiba, T., Yokosuka, O., Fukai, K., Hirasawa, Y., Tada, M., Mikata, R., Imazeki, F., Taniguchi, H., Iwama, A., Miyazaki, M., Ochiai, T., and Saisho, H. (2005) Identification and investigation of methylated genes in hepatoma. Eur. J. Cancer 41, 1185-1194.
99. Arai, M., Yokosuka, O., Hirasawa, Y., Fukai, K., Chiba, T., Imazeki, F., Kanda, T., Yatomi, M., Takiguchi, Y., Seki, N., Saisho, H., and Ochiai, T. (2006) Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-Aza-20-deoxycytidine. Cancer 106, 2514-2525.
100. Morris, M. R., Gentle, D., Abdulrahman, M., Clarke, N., Brown, M., Kishida, T., Yao, M., Teh, B. T., Latif, F., and Maher, E. R. (2008) Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. Br. J. Cancer 98, 496-501.
101. Eberharter, A., Ferreira, R., and Becker, P. (2005) Dynamic chromatin: concerted nucleosome remodelling and acetylation. Biol. Chem. 386, 745-751.
102. Drummond, D. C., Noble, C. O., Kirpotin, D. B., Guo, Z., Scott, G. K., and Benz, C. C. (2005) Clinical development of histone deacetylase inhibitors as anticancer agents. Ann. Rev. Pharmacol. Toxicol. 45, 495-528.
103. Schneider-Stock, R., and Ocker, M. (2007) Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors. IDrugs 10, 557-561.
104. Gray, S. G., De Meyts, P. (2005) Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab. Res. Rev. 21, 416-433.
105. Kee, H. J., Sohn, I. S., Nam, K. I., Park, J. E., Qian, Y. R., Yin, Z., Ahn, Y., Jeong, M. H., Bang, Y. J., Kim, N., Kim, J. K., Kim, K. K., Epstein, J. A., and Kook, H. (2006) Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113, 51-59.
106. Lee, T. M., Lin, M. S., and Chang, N. C. (2007) Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. Am. J. Physiol. Heart. Circ. Physiol. 293, H968-977.
107. Chiba, T., Yokosuka, O., Fukai, K., Kojima, H., Tada, M., Arai, M., Imazeki, F., and Saisho, H. (2004) Cell Growth Inhibition and Gene Expression Induced by the Histone Deacetylase Inhibitor, Trichostatin, A., on Human Hepatoma Cells. Oncology 66, 481-491.
108. Gray, S. G., Qian, C. N., Furge, K., Guo, X., and Teh, B. T. (2004) Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines. Int. J. Oncol. 24, 773-795.
109. Komorowsky, C., Ocker, M., and Goppelt-Struebe, M. Differential Regulation of Connective Tissue Growth Factor in Renal Cells by Histone Deacetylase Inhibitors. J. Cell. Mol. Med. 10.1111/j.1582-4934.2008.00674.x.
110. Duncan, M. R., Frazier, K. S., Abramson, S., Williams, S., Klapper, H., Huang, X., and Grotendorst, G. R. (1999) Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J. 13, 1774-1786.
111. Stratton, R., Shiwen, X., Martini, G., Holmes, A., Leask, A., Haberberger, T., Martin, G. R., Black, C. M., and Abraham, D. (2001) Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J. Clin. Invest. 108, 241-250.
112. Gressner, O. A., Lahme, B., Rehbein, K., Siluschek, M., Weiskirchen, R., and Gressner, A. M. (2008) Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J. Hepatol. 49, 758-767.